From Implandata receiving CE Marking to Inolife eyeing up-listing, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Dextera seeks expanded indications for MicroCutter 5/80 stapler Dextera Surgical announced in a June 1 press release that it has filed a 510(k) with the FDA for its MicroCutter 5/80 stapler. The […]
c2 Therapeutics
C2 Therapeutics touts ColdPlay ablation system study data
C2 Therapeutics today released data from a study of its ColdPlay cryoballoon focal ablation system reporting no adverse events or complications with the device. The Redwood City, Calif.-based company’s device is designed to treat precursors to esophageal cancer known as Barrett’s esophagus. The Coldplay device uses extreme cold to destroy targeted diseased tissue while minimizing […]
C2 Therapeutics Coldplay cryoballoon wins CE Mark
C2 Therapeutics said today its Coldplay cryoballoon focal ablation system won CE Mark approval in the European Union. The Redwood City, Calif.-based company’s device is designed to treat precursors to esophageal cancer known as Barrett’s Esophagus. The Coldplay device uses extreme cold to destroy targeted diseased tissue while minimizing damage to healthy tissue. “C2’s Coldplay […]
C2 Therapeutics wins 510(k)s for Coldplay cryoballoons
C2 Therapeutics said today it won FDA 510(k) clearances for its Coldplay cryoballoon full ablation system and swipe ablation system. The Redwood City, Calif.-based company’s devices are designed to treat precursors to esophageal cancer known as Barrett’s Esophagus. “The clearance of Coldplay Cryoballoon Full and Swipe Systems is an important milestone in broadening the company’s […]